Day: September 6, 2023

Substantial reductions in rate and risk of exacerbations support potential of ensifentrine, an investigational, novel, selective, dual inhibitor of PDE3 and PDE4 LONDON and RALEIGH, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces an oral presentation on an additional analysis from its successful Phase 3 ENHANCE-1 study with ensifentrine for the treatment of chronic obstructive pulmonary disease (“COPD”) will be presented at the European Respiratory Society (“ERS”) International Congress 2023. The abstract is available to conference attendees on the ERS website and will be published in an upcoming issue of the peer reviewed publication, European Respiratory Journal. The presentation will highlight additional analyses of the ENHANCE-1 24-week exacerbation data...

TURKU, Finland and BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, today announces that Dr Markku Jalkanen, PhD, CEO will present at the H.C. Wainwright Annual Global Investment Conference in New York City on September 12, 2023. In addition to the presentation, company management will be available for one-on-one meetings with investors. H.C. Wainwright Global Investment Conference Date: Tuesday, September 12, 2023Time: 10:30 a.m. ETLocation: Room Holmes I, 4th floorFormat: Company Presentation For more information please contact: Investor Contact LifeSci AdvisorsDaniel FerryManaging Directordaniel@lifesciadvisors.com+1 (617) 430-7576 Media Contact Faron PharmaceuticalsJennifer C....

First Production in 2026; Strong Project Economics with NPV of $550 Million and IRR 24%; Average Annual Production of 5,400 Tonnes of Battery-Quality Lithium Carbonate Over 25 YearsFigure 1Phase 1A Production PlanFigure 2Phase 1A Development TimelineEL DORADO, Ark., Sept. 06, 2023 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), announced today the positive results of a Definitive Feasibility Study (the “DFS”) for its first commercial lithium extraction plant project (“Phase 1A”) proposed to be located at the LANXESS South Plant (“South Plant”). The DFS considers first production of battery-quality lithium carbonate in 2026, using direct lithium extraction, from Smackover brine currently being produced by LANXESS Corporation (“LANXESS”) from...

Geneva, Switzerland, September 6, 2023 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that Tim Dyer, Chief Executive Officer, will be attending the H.C. Wainwright 25th Annual Global Investment Conference (September 11 – 13, 2023) in New York. A pre-recorded corporate presentation is scheduled for viewing on Monday, September 11, 2023, at 07:00 EDT. In his presentation, Mr Dyer will provide a corporate update and discuss recent developments at Addex. The presentation will be available for viewing on-demand via this link from the time of the presentation and subsequently on our Company’s website Events page. The video replay will be archived for 90 days following the event. Mr Dyer will be available for virtual...

06 September 2023 PRESS RELEASE Ad hoc announcement pursuant to Art. 53 Listing Rules: GAM convenes Extraordinary General Meeting of Shareholders The Board of Directors of GAM Holding AG (“GAM Board”) today convened an Extraordinary General Meeting (“EGM”) to be held in Zurich on 27 September 2023, 10am CEST. The EGM was requested by Rock Investment SAS (“Rock”) in connection with the public partial tender offer of Newgame SA, Geneva, Switzerland, for 28,000,000 publicly held registered shares with a par value of CHF 0.05 each of GAM Holding AG. Rock is a French-incorporated entity that is owned by NJJ Holding (“NJJ”), the personal holding company of Xavier Niel. It is part of the NewGAMe investor group, which consists of Newgame SA and Bruellan SA. The EGM agenda includes proposals from...

FOR IMMEDIATE RELEASE WISeKey’s WISe.ART, digital platform powered with cyber security, and CryptoVerse Island announce their support for the Maiti Nepal Foundation with an exclusive sale of art NFT to raise funds for young ladies’ university scholarships in Nepal ZUG, SWITZERLAND – September 6, 2023 – WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leader in cybersecurity, AI, Blockchain, and IoT operating as a holding company, that WISe.ART will support efforts of the Maiti Nepal Foundation (Maiti Nepal) to sponsor students who are pursuing higher secondary degrees, through funds raised from the sale of selected NFTs donated by artists and made available on the WISe.ART platform. Maiti is a beautiful word from the Nepali language, meaning a woman’s childhood home. Apart from being a beautiful word that...

Ad hoc announcement pursuant to Art. 53 LRAprocitentan, Idorsia’s oral, dual endothelin receptor antagonist is currently under review with health authorities for the treatment of patients with resistant hypertension. Idorsia will pay Janssen a conditional consideration up to a total cap of CHF 306 million Idorsia is initiating activities to determine the best approach to maximize the value of aprocitentan.Allschwil, Switzerland – September 6, 2023Idorsia Ltd (SIX: IDIA) today announced that it has entered into an agreement with Janssen Biotech Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, for the return of rights for aprocitentan to Idorsia. In return, Idorsia is committed to pay up to 306 million Swiss francs, subject to marketing application approval by the US FDA and Europe’s EMA. Jean-Paul Clozel,...

Frøya/Tromsø, 6. September 2023 When SalMar today welcomes participants to its 2023 Capital Markets Day in Tromsø, sustainable organic growth is on the top of the agenda. Following several successful transactions and the ongoing integration of NTS, NRS and SalmoNor, SalMar has established itself as a powerhouse in the international aquaculture industry. The company will maintain its commitment and ambitions within coastal farming and within offshore farming. SalMar aims to continue its leading role in growing and developing the industry both nationally and internationally.  “Our ambition is further growth in all the regions we operate, but where, how soon and how much we will invest will depend on where we find a sustainable regulatory framework. In Norway, the resource rent tax which has been introduced represents a particular cause for...

Amsterdam, 6 September 2023 – VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services (“the Company”), announces that it has issued a CEO Letter to current and potential investors, confirming the unhindered trading of its shares and offering the Company’s support to investors if they experience arbitrary obstacles to trading. In the letter, shared with the investor community on 5 September 2023, VEON Group CEO noted the following: “Dear Valued Investors, I am writing this letter to you to address some stock market observations that have recently come to our attention. We have noted that the trading volumes of our shares are unusually low, and have received reports suggesting that certain brokers are arbitrarily declining orders to purchase VEON shares. Allow...